Yumanity Therapeutics (YMTX) executive Iadonato sold 2,699 shares for $11.5K at an average $4.26
Insider transactions reported
Shawn Iadonato (executive at Yumanity Therapeutics Inc., YMTX) reported that they sold 2,699 shares for $11.5K at an average $4.26 between Mar 17, 2023 and Mar 20, 2023. After these transactions the filing shows 666,287 shares held directly.
- Reporting person
- Iadonato Shawn
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 17, 2023 | Open-market sale (S) | Common Stock1, 2 | -1,580 | avg $4.94 | $7,808 | 667,406 direct |
| Mar 20, 2023 | Open-market sale (S) | Common Stock1, 3 | -1,119 | $3.29 | $3,678 | 666,287 direct |
Holdings before and after
- Common Stock: 668,986 to 666,287 direct
Other positions listed
- Common Stock: 8,553 indirect, By IRA
Footnotes from the filing
- 1. Shares of the Issuer's Common Stock were sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's Common Stock in connection with the settlement of the vested portion of restricted stock units.
- 2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.22 to $5.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Iadonato report in this YMTX Form 4?
Shawn Iadonato (executive at Yumanity Therapeutics Inc., YMTX) reported that they sold 2,699 shares for $11.5K at an average $4.26 between Mar 17, 2023 and Mar 20, 2023. After these transactions the filing shows 666,287 shares held directly.
How many YMTX shares does Iadonato hold after this filing?
The filing shows 666,287 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this YMTX insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for YMTX
Earlier insider filings at YMTX
- Jan 4, 2023SEC Form 4: Bartoszek Raymond J. bought $43,581 worth of shares (7,001 units at $6.22), increasing direct ownership by 101% to 9,956 units
- Dec 21, 2022SEC Form 4: Philips Craig W. was granted 102,352 shares
- Dec 21, 2022SEC Form 4: Peters Richard covered exercise/tax liability with 1,931 shares, decreasing direct ownership by 2% to 88,097 units (withholding obligation)
- Dec 21, 2022SEC Form 4: Kenny Pauline was granted 19,117 shares
- Dec 21, 2022SEC Form 4: Iadonato Shawn was granted 677,539 shares
Keep researching YMTX
- YMTX insider tradesEvery buy and sale reported by Yumanity Therapeutics Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Follow YMTX and get a push notification the moment its next story breaks.